Company · CIK 0001127537 · SIC 3841 — Surgical & Medical Instruments & Apparatus · Nasdaq
Pulmonx Corp · LUNG
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 SForm 4 → | Sep 3, 6:23 pm EDT | Glendon E. French IIIPresident and CEO, Director | 41,882 | $2.26 | $94,653 | 1,137,936 | −3.55% | |
| Sep 1, 2026 SForm 4 → | Sep 3, 6:21 pm EDT | Srikanth RadhakrishnanChief Science & Techn. Officer | 14,245 | $2.26 | $32,194 | 316,994 | −4.30% | |
| Sep 1, 2026 SForm 4 → | Sep 3, 6:19 pm EDT | David Aaron LehmanGeneral Counsel | 14,334 | $2.26 | $32,395 | 361,827 | −3.81% | |
| Sep 1, 2026 SForm 4 → | Sep 3, 6:17 pm EDT | Geoffrey Beran RoseChief Commercial Officer | 7,879 | $2.26 | $17,807 | 449,832 | −1.72% | |
| Jun 5, 2026 AForm 4 → | Jun 9, 6:02 pm EDT | Thomas William BurnsDirector | 40,000 | — | — | 113,399 | — | |
| Jun 5, 2026 AForm 4 → | Jun 9, 6:01 pm EDT | Richard FerrariDirector | 40,000 | — | — | 127,024 | — | |
| Jun 5, 2026 AForm 4 → | Jun 9, 5:59 pm EDT | Daniel P FlorinDirector | 40,000 | — | — | 133,910 | — | |
| Jun 5, 2026 AForm 4 → | Jun 9, 5:56 pm EDT | Georgia MelenikiotouDirector | 40,000 | — | — | 139,714 | — | |
| Jun 5, 2026 AForm 4 → | Jun 9, 5:54 pm EDT | Tiffany SullivanDirector | 40,000 | — | — | 115,199 | — | |
| Jun 5, 2026 AForm 4 → | Jun 9, 5:49 pm EDT | Dana G Mead Jr.Director | 40,000 | — | — | 139,714 | — | |
| Jun 1, 2026 SForm 4 → | Jun 3, 4:18 pm EDT | Srikanth RadhakrishnanChief Science &Techn. Officer | 14,497 | $1.54 | $22,325 | 331,239 | −4.19% | |
| Jun 1, 2026 SForm 4 → | Jun 3, 4:17 pm EDT | David Aaron LehmanGENERAL COUNSEL | 14,594 | $1.54 | $22,475 | 376,161 | −3.73% | |
| Jun 1, 2026 SForm 4 → | Jun 3, 4:16 pm EDT | Geoffrey Beran RoseCHIEF COMMERCIAL OFFICER | 8,023 | $1.54 | $12,355 | 457,711 | −1.72% | |
| Jun 1, 2026 SForm 4 → | Jun 3, 4:15 pm EDT | Glendon E. French IIIPresident and CEO, Director | 56,149 | $1.55 | $86,875 | 1,178,162 | −4.55% |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.